The relationship between oncology nurses and the pharmaceutical industry is often misunderstood. This webinar is designed to demystify pharma, challenge common misconceptions, and provide a clear, practical understanding of how oncology nurses can effectively and ethically engage with industry to improve patient care.
In this session we will explore how modern pharmaceutical and biotechnology companies are structured, how they develop and bring therapies to patients, and - critically - how roles within these organisations are evolving.
In particular, the session will highlight the growing importance of Medical and Patient Affairs as a scientific, patient-focused function that acts as a bridge between research, clinical practice and real-world patient needs.
By the end of this webinar, participants will have a clearer understanding of:
How the pharmaceutical industry works in practice
Where and how nurses can engage meaningfully with pharma
The opportunities to shape education, research and patient outcomes
How to navigate these interactions with confidence, integrity and impact.


Medical Director, Edge Medical
Matt Britland is a Medical Affairs leader with over 25 years’ experience across clinical practice, the pharmaceutical industry, and academia. He began his career as an oncology nurse at The Christie Hospital in the UK in the late 1990s, before studying medicines development and transitioning into a career in Medical Affairs, primarily in oncology.
He has held senior roles across medical strategy, field medical, and capability development in oncology, immunology, and rare diseases, and is currently completing a DrPH at UNSW focused on the impact of Medical Affairs on quality use of medicines (QUM).
A former President of MAPA (Medical Affairs Professionals of Australasia) and member of the MAPS APAC Steering Committee, Matthew has contributed to advancing Medical Affairs capability across the region. He also lectures in Oncology Therapeutics and Medical Affairs at UNSW and the University of Sydney.
He is passionate about strengthening collaboration between clinicians and industry to improve patient outcomes.
Please accept {{cookieConsents}} cookies to view this content